Ardelyx, Inc. (ARDX) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference Transcript
Question-and-Answer SessionMichael RaabPresident, CEO & Director Sure. Bob, so thank you for the invitation, Morgan Stanley. We're really happy to be here. And share some of the perspectives that we have on where we are today with Ardelyx. So it's been -- when the idea for tenapanor was presented to the Board, it was December 23, 2008. And to see the evolution of the company to where we are today, where we've given guidance now for IBSRELA from 260 million this year. I don't think people an ...